NewSquare Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
NP
DADC
TWC
BEI
DWP
HFM
AFA
NewSquare Capital's FBT Position: Q2 2026 in Review
NewSquare Capital increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 20% in Q2 2026, buying an estimated $1.76M and bringing the position to 49,037 shares worth $12.2M. The position accounts for 0.9% of the portfolio, ranked #23.
NewSquare Capital first reported a position in FBT in Q4 2013 and has held it in 20 quarters since. The position peaked at $17.4M in Q1 2019. 143 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- NewSquare Capital held 49,037 shares of First Trust NYSE Arca Biotechnology Index Fund worth $12.2M as of Q2 2026.
- NewSquare Capital bought 8,152 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.76M.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.9% of NewSquare Capital's portfolio in Q2 2026, its #23 holding.
- NewSquare Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and has held it in 20 quarters since.
- NewSquare Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $17.4M in Q1 2019.
- 143 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on NewSquare Capital's 13F filing for Q2 2026, filed 28 Jul 2026.